Microbiology
A complete guide to the science of microorganisms — from bacterial structure, classification, and genetics through viral replication strategies, fungal biology, and parasitology, to microbial pathogenesis, the host immune response, antimicrobial mechanisms, antibiotic resistance, biofilms, the human microbiome, and clinical and environmental applications.
The living world visible to the naked eye is the smallest fraction of the living world that exists. Below the threshold of human perception lies a microbial universe of extraordinary diversity — bacteria that survive in volcanic vents at 120°C and in the Antarctic ice sheet simultaneously, viruses that have colonised every ecosystem on Earth including the human body, fungi that decompose dead matter and produce the compounds that have saved more lives than any other class of medicines, and parasites whose life cycles pass through multiple hosts with elaborate precision. Microbiology is the science that studies this invisible majority — and its implications reach into medicine, agriculture, food safety, environmental science, biotechnology, and the most fundamental questions about the origin and nature of life. For students in healthcare, biological sciences, and public health, microbiology is not background knowledge — it is the mechanistic foundation of infectious disease, the basis of most clinical diagnostic decision-making, and the framework for understanding one of the defining public health challenges of the century: antimicrobial resistance.
Microbiology — Scope, Sub-Disciplines, and Historical Foundations
Microbiology (from Greek mikros, small; bios, life; logos, study) is the scientific study of organisms too small to be seen with the unaided eye — encompassing bacteria, viruses, fungi, archaea, protozoa, algae, and other microscopic entities. The field’s scope extends from the fundamental biology of individual microbial cells through the ecology of microbial communities, the mechanisms by which microorganisms cause disease, and the science of controlling or exploiting microbial activities for human benefit. Its sub-disciplines reflect the diversity of microorganisms and their applications across science and medicine.
Historical Milestones That Shaped Modern Microbiology
1676 — Leeuwenhoek’s microscopes: The first observation of bacteria (“animalcules”) in pond water and dental scrapings, establishing that microorganisms exist and can be observed. 1860s — Pasteur’s germ theory: Louis Pasteur’s swan-neck flask experiments disproved spontaneous generation and established that fermentation and disease are caused by specific microorganisms. 1876–1884 — Koch’s postulates: Robert Koch established the experimental criteria for proving a microorganism causes a specific disease, isolating the causative agents of anthrax and tuberculosis. 1928 — Fleming’s penicillin: Alexander Fleming observed that Penicillium mould inhibited bacterial growth — the observation that launched the antibiotic era. 1953 — DNA double helix: Watson and Crick’s structure of DNA, informed by Rosalind Franklin’s X-ray data, laid the foundation for molecular microbiology and understanding of microbial genetics. 2000s — Metagenomics: Culture-independent sequencing technologies revealed the vast majority of environmental and human-associated microorganisms that cannot be grown in laboratory culture.
Clinical Microbiology
The identification and characterisation of infectious agents causing human disease — directing diagnosis, treatment, and infection control through culture, sensitivity testing, serology, and molecular diagnostics. Directly informs antibiotic prescribing, outbreak investigation, and hospital infection control.
Industrial and Applied Microbiology
Exploiting microbial metabolism for human benefit — producing antibiotics, enzymes, vitamins, biofuels, fermented foods, and biopolymers; bioremediation of contaminated environments; and biotechnological production of therapeutic proteins. The global fermentation industry is built on microbial biochemistry.
Environmental Microbiology
The study of microorganisms in natural environments — soil, water, air, and extreme habitats. Environmental microorganisms drive the major biogeochemical cycles: carbon, nitrogen, sulphur, and phosphorus cycling that sustain all life on Earth. Includes the study of microbial communities by culture-independent metagenomic methods.
Bacterial Structure and Classification — Understanding the Prokaryotic Cell
Bacteria are prokaryotic single-celled organisms — they lack the membrane-bound nucleus and membrane-delimited organelles of eukaryotic cells. Despite this structural simplicity relative to eukaryotes, bacteria are metabolically diverse, structurally varied, and ecologically ubiquitous — occupying every habitat on Earth from hydrothermal vents to human mucosal surfaces. Understanding bacterial cell structure is the foundation for understanding antibiotic mechanisms, virulence factors, and diagnostic techniques.
Cell Membrane and Cell Wall
The bacterial plasma membrane is a phospholipid bilayer containing membrane proteins essential for transport, energy generation (electron transport chain in aerobic bacteria), and signalling. Unlike eukaryotic membranes, it generally lacks sterols (except Mycoplasma). The cell wall — present in most bacteria — provides structural integrity against osmotic lysis and determines the Gram stain result. Gram-positive bacteria have a thick (15–80 nm) peptidoglycan layer; Gram-negative bacteria have a thin (2–7 nm) peptidoglycan layer plus an outer membrane containing lipopolysaccharide (LPS), a potent immunostimulatory molecule (endotoxin) that drives septic shock.
Flagella — Motility and Virulence
Bacterial flagella are rotary motors driven by a proton gradient (proton motive force) across the plasma membrane. The flagellar motor — built from approximately 40 different proteins — can rotate at 100–1,000 rpm, propelling bacteria at up to 60 μm/s (30 body lengths per second). Flagella are used not only for motility but as virulence factors: flagellin is a pathogen-associated molecular pattern (PAMP) recognised by TLR5 on host innate immune cells, activating inflammatory responses. The arrangement of flagella (monotrichous — one polar; lophotrichous — multiple at one pole; amphitrichous — both poles; peritrichous — all around) is taxonomically useful.
Pili and Fimbriae — Attachment and Conjugation
Pili (singular: pilus) and fimbriae are filamentous protein appendages projecting from the bacterial surface. Short, numerous fimbriae mediate adhesion to host cell surfaces — a critical first step in colonisation and infection. Type 1 fimbriae of Escherichia coli mediate attachment to mannose-containing receptors in the urinary tract, explaining the organism’s prevalence in urinary tract infections. The sex pilus — longer, fewer, and structurally distinct — forms the conjugation tube through which plasmid DNA is transferred between bacteria during horizontal gene transfer. The type IV pilus is used for both motility (twitching motility) and adhesion in organisms such as Neisseria gonorrhoeae and Pseudomonas aeruginosa.
Capsule — Immune Evasion
Many pathogenic bacteria produce a capsule — a polysaccharide or polypeptide layer external to the cell wall. The capsule is a major virulence factor: it prevents phagocytosis by coating the bacterium and preventing recognition by phagocyte receptors (opsonisation requires antibodies and complement components to bind and overcome capsule protection). Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis are encapsulated pathogens — and the capsular polysaccharides form the basis of the vaccines against these organisms. Capsule production is linked to the mucoid colony morphology observed on culture plates, particularly in Klebsiella pneumoniae and mucoid Pseudomonas aeruginosa in cystic fibrosis.
Endospores — Extreme Dormancy
Certain Gram-positive genera — primarily Bacillus and Clostridium — form endospores in response to nutrient deprivation or environmental stress. An endospore is a metabolically dormant, highly resistant structure containing the bacterial chromosome protected by multiple layers including the spore coat, cortex, and inner membrane. Endospores survive boiling, dessication, UV radiation, and many disinfectants — only moist heat at 121°C (autoclaving) reliably destroys them. Clinically significant: Clostridioides (formerly Clostridium) difficile spores persist on hospital surfaces for months; Bacillus anthracis spores were used as a bioterrorism agent in the 2001 US anthrax letters. Endospore staining (Schaeffer-Fulton method, using malachite green) identifies spore-forming organisms.
Nucleoid, Plasmids, and Transposable Elements
The bacterial chromosome is a single, typically circular, double-stranded DNA molecule compacted into the nucleoid region — not a membrane-bound nucleus. Human-associated bacteria have genomes of approximately 1–10 Mb (compared to 3,200 Mb in humans). Plasmids are smaller, extrachromosomal circular DNA molecules that replicate autonomously and carry accessory genes — including antibiotic resistance genes, virulence factors, and metabolic capabilities. Transposons (transposable elements) are DNA segments that can move within or between DNA molecules, contributing to genome plasticity and resistance gene mobilisation. Together these mobile genetic elements enable rapid adaptation to new environments and selective pressures.
Gram Staining — The Cornerstone Differential Technique in Bacteriology
The Gram stain, developed by Danish bacteriologist Hans Christian Gram in 1884, remains the single most important diagnostic procedure in clinical bacteriology — a 15-minute test that divides bacteria into two groups with profoundly different cell wall architectures, antibiotic susceptibilities, and clinical significance. It is typically the first test performed on a clinical specimen and guides empirical antibiotic therapy hours before culture results are available.
Crystal Violet — Primary Stain
Crystal violet (gentian violet) is applied to a heat-fixed smear. The dye penetrates all bacterial cells — Gram-positive and Gram-negative — staining both purple. The dye forms complexes with the peptidoglycan and cellular contents of all bacteria at this stage. No differentiation has occurred yet; all bacteria appear purple under the microscope.
Gram’s Iodine — Mordant
Iodine solution is applied, forming large crystal violet-iodine (CV-I) complexes within the bacteria. These complexes are too large to pass easily through the cell walls. All bacteria remain purple. Iodine serves as a mordant — it fixes the primary stain in place and prepares for the critical decolorisation step. The size of the CV-I complex relative to the pores in the peptidoglycan layer determines the outcome of the next step.
Alcohol or Acetone — Decolorisation (The Critical Step)
This is where Gram-positive and Gram-negative bacteria diverge. In Gram-positive bacteria, alcohol dehydrates the thick peptidoglycan layer — tightening its pores and trapping the CV-I complexes inside. They retain the purple stain. In Gram-negative bacteria, alcohol dissolves the lipid outer membrane — creating large holes through which the CV-I complexes are rapidly washed out. The thin peptidoglycan layer cannot retain them. Gram-negative cells are left colourless. This is the step that differentiates the two groups — the duration of decolorisation must be controlled precisely; over-decolorisation makes Gram-positive organisms appear Gram-negative (false Gram-negative result).
Safranin — Counterstain
Safranin (a red dye) is applied as a counterstain. Gram-positive cells, already saturated with purple crystal violet, absorb little additional safranin and remain purple/violet. Gram-negative cells, now colourless, absorb the safranin and become pink/red. The result: Gram-positive bacteria are purple, Gram-negative bacteria are pink. The morphology (cocci, bacilli, diplococci, chains, clusters) and arrangement of the stained bacteria provide additional diagnostic information that narrows the differential diagnosis before culture results.
Bacterial Genetics and Horizontal Gene Transfer — Rapid Adaptation in Action
Bacteria have a generation time of 20–30 minutes under optimal conditions — meaning that in a single day, a bacterial culture can pass through 50 or more generations. This rapid reproduction, combined with the large population sizes bacteria achieve, means that rare mutants arise constantly. More importantly, bacteria can acquire entirely new genetic capabilities — including antibiotic resistance genes — from other bacteria through horizontal gene transfer (HGT), bypassing the generational time requirement entirely. HGT is the primary mechanism by which antibiotic resistance spreads across bacterial species and genera, and understanding it is essential for understanding the resistance crisis.
TRANSFORMATION — Uptake of naked environmental DNA Frequency: Low; requires natural competence or laboratory electroporation DNA source: Dead bacterial cells releasing chromosomal or plasmid DNA Selective: Only naturally competent bacteria (e.g. S. pneumoniae, H. influenzae, N. meningitidis) Clinical import: Penicillin resistance in S. pneumoniae via mosaic PBP genes from oral streptococci TRANSDUCTION — Bacteriophage-mediated DNA transfer Frequency: Low–medium; requires phage infection DNA source: Packaged bacterial DNA accidentally incorporated into phage capsids Types: Generalised (any DNA) or specialised (adjacent to phage integration site) Clinical import: Shiga toxin genes in EHEC O157:H7 encoded on lambda-like prophages CONJUGATION — Direct cell-to-cell plasmid transfer Frequency: High; can occur between distantly related species DNA source: Self-transmissible or mobilisable plasmids transferred through sex pilus Requires: Cell-to-cell contact; tra (transfer) genes on conjugative plasmid Clinical import: PRIMARY MECHANISM for spread of R plasmids (multi-drug resistance plasmids) ESBLs, carbapenemases (NDM-1, KPC, OXA-48) spread between Enterobacterales via conjugation TRANSPOSONS — Mobile genetic elements within and between DNA molecules Function: Move resistance genes between chromosome, plasmids, and phages Integrons: Capture and express gene cassettes; accumulate multiple resistance genes ICEs: Integrative and conjugative elements — conjugative + integrative capability
The CRISPR-Cas System — Bacterial Adaptive Immunity
Bacteria are not passive recipients of horizontal gene transfer — they have evolved immune systems against invading phage DNA and unwanted plasmids. The CRISPR-Cas (Clustered Regularly Interspaced Short Palindromic Repeats — CRISPR-associated proteins) system provides a form of adaptive immunity by recording molecular memories of previous infections. When a bacterium survives a phage infection, short sequences from the phage genome are integrated into CRISPR arrays in the bacterial chromosome. If the same phage infects again, CRISPR RNA transcribed from these arrays guides the Cas nuclease to cut the phage DNA — destroying it before it can replicate. The discovery of this system by Jennifer Doudna, Emmanuelle Charpentier, and colleagues — leading to the development of CRISPR-Cas9 gene editing — earned Doudna and Charpentier the Nobel Prize in Chemistry in 2020. The CRISPR-Cas9 system has been repurposed as the most widely used gene-editing tool in molecular biology and medicine.
Bacterial Growth, Metabolism, and Reproduction
Bacterial growth — the increase in population size by binary fission — follows a characteristic four-phase pattern when bacteria are introduced into a closed culture system (batch culture). Each phase reflects the interaction between bacterial physiology and the availability of nutrients, the accumulation of waste products, and the physical constraints of the culture environment. Understanding this growth pattern is foundational for clinical microbiology (predicting infection dynamics), food microbiology (predicting spoilage and pathogen growth), and industrial microbiology (optimising fermentation processes).
Lag Phase — Physiological Adaptation
Following inoculation into a new medium, bacteria enter a lag phase of no net increase in cell number. Bacteria are metabolically active — synthesising enzymes, cofactors, and ribosomal RNA needed to utilise the available nutrients — but have not yet begun dividing. The duration depends on how different the new medium is from the previous growth conditions: bacteria transferred from the same medium will have a short lag; bacteria transferred from a rich to a minimal medium will have a prolonged lag as they induce the biosynthetic pathways required. In food safety, the lag phase is exploited by refrigeration — cold temperatures extend the lag phase dramatically, delaying pathogen growth to unsafe numbers.
Log (Exponential) Phase — Maximum Growth Rate
During the log phase, bacteria divide at the maximum rate permitted by the nutritional environment — the generation time (doubling time) is constant and at its minimum. E. coli divides every 20 minutes under optimal conditions; S. pneumoniae every 30–40 minutes; Mycobacterium tuberculosis every 15–20 hours. The log phase produces the most metabolically active, physiologically uniform population — making it the preferred phase for biochemical experiments, antibiotic susceptibility testing (antibiotics are most effective against actively dividing bacteria), and production of metabolites in industrial fermentation. The exponential relationship means that a small number of contaminating bacteria can reach dangerous levels within hours at body temperature.
Stationary Phase — Growth Arrest
Growth slows and eventually halts as nutrients become depleted, toxic waste products (acids, CO₂) accumulate, and oxygen becomes limiting (for aerobes). The bacterial population stabilises — the rate of new cell production equals the rate of cell death. Bacteria in stationary phase are physiologically distinct from log-phase cells: they activate stress response programmes (the stringent response and the RpoS sigma factor regulon), become more resistant to antibiotics (because many antibiotics target active growth processes), and may form biofilms or spores. Secondary metabolite production — including many antibiotics like penicillin from Penicillium and streptomycin from Streptomyces — occurs primarily in the stationary phase.
Death Phase — Exponential Cell Death
Cell death exceeds new cell production as the environment becomes increasingly hostile — nutrient depletion, toxic waste accumulation, and autolysis (self-digestion by bacterial enzymes) drive an exponential decline in viable cell numbers. Some cells may persist in a dormant, persister state — a small subpopulation of phenotypically antibiotic-tolerant cells that survive lethal antibiotic concentrations by entering a metabolically arrested state. Persisters are not genetically resistant mutants but phenotypic variants that represent a bet-hedging strategy; they can reseed infection after antibiotic treatment ends, explaining why some chronic infections relapse despite apparently adequate antibiotic therapy.
Nutritional Classification of Bacteria
Bacteria are classified by carbon and energy source. Chemoorganoheterotrophs (the majority of clinically significant bacteria) use organic compounds as both carbon source and energy source — as do humans. Chemolithotrophs use inorganic compounds for energy (sulphur-oxidising, iron-oxidising, nitrifying bacteria in environmental settings). Phototrophs use light for energy (cyanobacteria, green and purple sulphur bacteria). Oxygen requirement further classifies bacteria as obligate aerobes (e.g. Mycobacterium tuberculosis), microaerophiles (e.g. Helicobacter pylori, Campylobacter), facultative anaerobes (e.g. E. coli — grow with or without oxygen), aerotolerant anaerobes (e.g. Streptococcus — tolerate oxygen but do not use it), and obligate anaerobes (e.g. Bacteroides, Clostridium — killed by oxygen).
Environmental Growth Requirements
Temperature range classifies bacteria as psychrophiles (optimal growth below 15°C — relevant to food spoilage in refrigerators), mesophiles (optimal 20–45°C — includes virtually all human pathogens), thermophiles (optimal 50–80°C — important in industrial applications and as models for heat-stable enzymes including Taq polymerase used in PCR), and hyperthermophiles (optimal above 80°C — archaea in volcanic vents). pH requirements range from acidophiles (Helicobacter pylori thrives at pH 2–3 in the stomach) to alkaliphiles. Water activity (aw) and salt concentration (NaCl) requirements determine where organisms can grow — important in food preservation by salting and drying.
Virology — Viral Structure, Classification, and Replication Strategies
Viruses are the most abundant biological entities on Earth — with estimates of 10³¹ virus particles in the ocean alone — yet they are not independently living organisms. They are obligate intracellular parasites: entities consisting of genetic material (DNA or RNA) packaged in a protein coat (capsid), sometimes surrounded by a lipid membrane (envelope), that can only reproduce by commandeering the metabolic machinery of a host cell. The diversity of viral structures, genome types, and replication strategies is extraordinary, and classifying this diversity is one of the ongoing challenges of virology.
The Baltimore Classification — Organising Viral Diversity by Genome and Replication Strategy
The Baltimore classification system, devised by Nobel laureate David Baltimore, groups viruses into seven classes based on their genome type and the strategy used to produce mRNA — which is the common requirement for protein synthesis in all viruses. The classification predicts the replication strategy, the host enzymes required or encoded, and the drug targets available for each viral class.
Class I — Double-stranded DNA (dsDNA): Herpesviruses, adenoviruses, poxviruses. Replicate in the nucleus (except poxviruses); use host DNA-dependent RNA polymerase. Targets: viral thymidine kinase (aciclovir for herpesviruses), viral DNA polymerase.
Class II — Single-stranded DNA (ssDNA): Parvoviruses (including human parvovirus B19, causing fifth disease and aplastic crisis in haemolytic anaemia). Must convert to dsDNA before transcription.
Class III — Double-stranded RNA (dsRNA): Reoviruses, rotavirus (major cause of childhood gastroenteritis globally). Encode their own RNA-dependent RNA polymerase (RdRp) — host cells have no dsRNA replication machinery.
Class IV — Positive-sense single-stranded RNA (+ssRNA): Coronaviruses (SARS-CoV-2), SARS, MERS, hepatitis C, poliovirus, rhinovirus, flaviviruses (dengue, Zika, yellow fever). Genome directly translatable as mRNA. Drug targets include viral RdRp (remdesivir, sofosbuvir) and viral proteases.
Class V — Negative-sense single-stranded RNA (−ssRNA): Influenza, measles, rabies, Ebola, RSV. Cannot be directly translated — must first make a +ssRNA copy using viral RdRp brought into the cell with the virus. Target: viral RNA polymerase, neuraminidase (oseltamivir for influenza).
Class VI — Retroviruses (ssRNA with DNA intermediate): HIV, HTLV. Reverse transcriptase converts RNA genome to dsDNA, which integrates into host chromosome. Targets: reverse transcriptase (NRTIs, NNRTIs), integrase (dolutegravir), protease (ritonavir).
Class VII — Pararetroviruses (dsDNA with RNA intermediate): Hepatitis B virus. Unique: replicates through an RNA intermediate (pregenomic RNA) converted back to DNA by reverse transcriptase. Target: viral reverse transcriptase (tenofovir, entecavir).
Mycology — Medically Important Fungi and Fungal Disease
Fungi are eukaryotic organisms — they have membrane-bound nuclei, mitochondria, and elaborate endomembrane systems. They are heterotrophic (obtaining carbon from organic sources) and reproduce both sexually and asexually. Unlike bacteria and viruses, fungi are more closely related to animals than to plants, which has profound implications for antifungal pharmacology: drug targets in fungi must be absent in human cells, but the closer evolutionary relationship means the available target set is smaller than for antibacterial drugs. Fungal diseases (mycoses) range from superficial dermatophyte infections to life-threatening systemic infections in immunocompromised patients.
Superficial and Cutaneous Mycoses
Dermatophytes — Trichophyton, Microsporum, Epidermophyton species — cause tinea infections (ringworm, athlete’s foot, nail infections). They digest keratin and are confined to superficial keratinised tissues. Diagnosed by KOH preparation (dissolves keratin, revealing fungal hyphae and spores) and culture on Sabouraud’s agar. Treatment: topical azoles or terbinafine; oral terbinafine or itraconazole for nail infections.
Systemic Primary Mycoses
Histoplasma capsulatum, Coccidioides immitis, Blastomyces dermatitidis — thermally dimorphic fungi (mould in environment, yeast at body temperature) causing pulmonary and systemic disease in immunocompetent hosts in endemic regions (Ohio/Mississippi river valley for Histoplasma; southwestern US for Coccidioides). Often self-limiting, but can cause severe disseminated disease. Treated with itraconazole (mild-moderate) or amphotericin B (severe).
Opportunistic Mycoses — Immunocompromised Patients
Candida species (commonest cause of invasive fungal infection in hospitals), Aspergillus fumigatus (invasive aspergillosis in neutropenic patients — high mortality), Cryptococcus neoformans (meningitis in HIV/AIDS), and Pneumocystis jirovecii (pneumocystis pneumonia, PCP — the AIDS-defining illness) cause life-threatening systemic infections exclusively or predominantly in immunocompromised hosts. Prophylaxis and empirical treatment are standard in high-risk patient groups.
Polyenes (amphotericin B, nystatin): Bind ergosterol in the fungal membrane, forming pores that cause leakage of cellular contents. Amphotericin B is the most broad-spectrum antifungal and the drug of choice for severe systemic mycoses; nephrotoxicity is the primary limiting adverse effect. Nystatin is used topically only.
Azoles (fluconazole, itraconazole, voriconazole, posaconazole): Inhibit CYP51 (lanosterol 14α-demethylase), a cytochrome P450 enzyme that converts lanosterol to ergosterol — depleting the membrane of ergosterol and disrupting membrane integrity. The most widely used antifungal class; voriconazole is first-line for invasive aspergillosis.
Echinocandins (caspofungin, micafungin, anidulafungin): Inhibit (1,3)-β-glucan synthase — an enzyme essential for fungal cell wall synthesis that has no human equivalent, making echinocandins highly selective with excellent tolerability. First-line for invasive candidiasis. Not active against Cryptococcus (which has little cell wall glucan) or Mucormycetes.
Parasitology — Protozoa, Helminths, and Their Interactions With Human Hosts
Parasitology encompasses the study of eukaryotic organisms that live in or on host organisms and obtain nutrients at the host’s expense. In medical parasitology, the principal groups are protozoa (single-celled eukaryotes — including plasmodium, trypanosomes, Giardia, and Cryptosporidium) and helminths (multicellular worms — nematodes, trematodes, and cestodes). Parasitic diseases are among the most significant causes of human morbidity and mortality globally — malaria alone kills approximately 600,000 people annually, predominantly sub-Saharan African children under five.
Malaria — Plasmodium Species
Four Plasmodium species cause human malaria: P. falciparum (most severe, responsible for nearly all deaths), P. vivax and P. ovale (relapsing malaria — persistent liver hypnozoites), P. malariae (chronic low-grade infection), and P. knowlesi (zoonotic, from macaques in Southeast Asia). Transmitted by female Anopheles mosquitoes. The life cycle passes through hepatocytes (liver phase — asymptomatic) and erythrocytes (blood phase — cyclical fever, anaemia, severe disease from P. falciparum rosetting and sequestration). Treatment: artemisinin-based combination therapies (ACTs) for uncomplicated malaria; IV artesunate for severe disease. Drug resistance (to chloroquine, mefloquine, and artemisinin) is a major and growing problem.
Giardia, Cryptosporidium, and Entamoeba
Giardia intestinalis causes giardiasis — the most common intestinal protozoan infection globally — presenting as persistent diarrhoea and malabsorption; transmitted by faecally contaminated water. Cryptosporidium parvum causes self-limiting diarrhoea in immunocompetent hosts but life-threatening infection in HIV/AIDS patients — it is the leading cause of waterborne diarrhoeal disease outbreaks in developed countries. Entamoeba histolytica causes amoebic dysentery and amoebic liver abscess (from haematogenous spread from the gut) in endemic areas. Diagnosis typically by stool microscopy for cysts/oocysts or antigen detection; molecular methods increasingly used.
Ascaris, Hookworm, Filariasis, and Toxocara
Nematodes are the most prevalent parasites on Earth. Ascaris lumbricoides (giant roundworm) infects approximately 800 million people; hookworms (Ancylostoma, Necator) cause iron deficiency anaemia from blood-sucking in the intestine. Lymphatic filariasis (Wuchereria bancrofti, Brugia) causes elephantiasis. Onchocerca volvulus causes river blindness. Strongyloides stercoralis undergoes autoinfection and causes hyperinfection syndrome in immunosuppressed patients. Toxocara canis/cati causes visceral larva migrans in children. Treatment: albendazole (broad-spectrum benzimidazole) for most; ivermectin for onchocerciasis and strongyloides; diethylcarbamazine for filariasis.
Schistosoma and Liver Flukes
Schistosomiasis (bilharzia) — caused by Schistosoma mansoni, S. haematobium, and S. japonicum — is the second most prevalent parasitic infection after malaria, affecting approximately 240 million people in tropical regions. The cercariae (infective larvae) penetrate skin directly from freshwater. Hepatosplenic disease and bladder carcinoma (S. haematobium) are major complications. Liver flukes — Fasciola hepatica (sheep liver fluke, zoonosis) and Clonorchis sinensis (from raw fish consumption) — infect bile ducts, causing biliary obstruction and carcinoma. Praziquantel is the drug of choice for all schistosome and most fluke infections.
Taenia and Echinococcus
Taenia saginata (beef tapeworm) and T. solium (pork tapeworm) cause intestinal infection; T. solium larvae can also cause neurocysticercosis — cystic lesions in the brain that are the most common cause of acquired epilepsy in developing countries. Echinococcus granulosus (dog tapeworm) causes cystic echinococcosis (hydatid disease) — large cysts in the liver and lungs that grow over years and rupture with anaphylactic consequences. Echinococcus multilocularis causes alveolar echinococcosis, a more aggressive condition behaving like a malignancy. Treatment: praziquantel (intestinal cestodes); albendazole + surgical/percutaneous drainage for hydatid disease.
Trypanosomiasis and Leishmaniasis
African trypanosomiasis (sleeping sickness) — caused by Trypanosoma brucei gambiense and T. b. rhodesiense — is transmitted by tsetse flies and causes progressive CNS disease culminating in coma and death without treatment. Chagas disease (American trypanosomiasis) — caused by T. cruzi — causes acute febrile illness and chronic cardiomyopathy and megaviscera. Leishmaniasis — caused by multiple Leishmania species — presents as cutaneous, mucocutaneous, or visceral (kala-azar) disease depending on species and host immunity, transmitted by sandfly bites. Treatment: varied and often toxic; pentamidine, melarsoprol (African trypanosomiasis); benznidazole (Chagas); liposomal amphotericin B or miltefosine (visceral leishmaniasis).
Archaea — The Third Domain and Their Medical Significance
Archaea represent the third domain of life — distinct from both Bacteria and Eukarya at the most fundamental phylogenetic level. Archaea share some features with bacteria (no membrane-bound nucleus, similar size) and some with eukaryotes (similar ribosomal proteins, similar transcription and translation machinery) but are uniquely characterised by: ether-linked membrane lipids (rather than the ester-linked lipids of bacteria and eukaryotes), unique cell wall compositions (none contain peptidoglycan), and distinctive metabolic strategies including methanogenesis (methane production) — found only in archaea.
Extremophile Archaea
Hyperthermophiles (Sulfolobus, Thermoproteus) thrive above 80°C in volcanic vents. Halophiles (Halobacterium) live in salt lakes at >20% NaCl. Acidophiles survive at pH 0–3. Psychrophiles colonise Antarctic ice. These organisms are the source of heat-stable enzymes — including Taq polymerase from Thermus aquaticus (also a thermophilic bacterium) used in PCR — and novel lipids, pigments, and polymers of biotechnological interest.
Methanogens and the Carbon Cycle
Methanogens are strictly anaerobic archaea that produce methane (CH₄) from CO₂ and H₂ or from acetate — a key step in anaerobic decomposition of organic matter in wetlands, sediments, and the guts of ruminants and termites. Methane is a potent greenhouse gas (28× more warming potential than CO₂ over 100 years), making methanogen ecology directly relevant to climate science. Methanogens in the human gut (primarily Methanobrevibacter smithii) influence hydrogen disposal and the efficiency of fermentation — with links to inflammatory bowel disease and obesity under investigation.
Archaea and Human Health
For many years archaea were considered non-pathogenic. Evidence is now emerging for archaeal contributions to the human gut, oral, and skin microbiomes, and for possible involvement in conditions including periodontal disease, colorectal cancer, and inflammatory bowel disease. Methanobrevibacter species are consistently found in the gut microbiome. Because archaea lack peptidoglycan, they are inherently resistant to beta-lactam antibiotics — a consideration if archaeal infections emerge as clinical entities.
Microbial Pathogenesis — How Microorganisms Cause Disease
Pathogenesis is the process by which a microorganism causes disease in a host. Not all microorganisms are pathogens, and even pathogenic organisms require specific conditions to produce disease — a sufficient infecting dose, a susceptible host, an appropriate route of entry, and the right virulence factor repertoire for the specific host-pathogen encounter. Understanding pathogenesis mechanisms is essential for understanding why specific infections present with specific clinical features, why some populations are more susceptible than others, and how to target interventions at critical points in the disease process.
Host Immune Response to Microorganisms
The immune response to microbial pathogens involves coordinated activation of innate and adaptive immune mechanisms, each adapted to detect and eliminate different types of pathogens through distinct effector mechanisms. The innate immune system provides rapid, non-specific protection by recognising conserved microbial structures (pathogen-associated molecular patterns, PAMPs) through pattern recognition receptors (PRRs). The adaptive immune system provides antigen-specific, immunological memory-based protection through T and B lymphocyte activation — a response that takes 5–10 days to develop but provides lasting protection.
Physical Barriers
Skin, mucous membranes, cilia, mucus, gastric acid (pH 1–3), bile salts, urinary flow, commensal microbiota (competitive exclusion) — the first-line defences that prevent most pathogens from establishing infection
Innate Immunity
TLRs and other PRRs detect PAMPs (LPS, flagellin, peptidoglycan, viral dsRNA). Activation triggers NF-κB signalling, cytokine production (TNF-α, IL-1β, IL-6, IL-12), neutrophil recruitment, complement activation, and NK cell cytotoxicity — within minutes to hours
Adaptive Immunity
CD4+ T helper cells coordinate adaptive response; CD8+ cytotoxic T cells kill infected host cells; B cells produce antigen-specific antibodies (IgM, IgG, IgA, IgE) after T cell help. Immunological memory enables rapid secondary response on re-exposure — the basis of vaccination
Vaccination
Live attenuated vaccines (MMR, yellow fever, oral polio), inactivated vaccines (influenza, hepatitis A), subunit/conjugate vaccines (pneumococcal, meningococcal), toxoid vaccines (tetanus, diphtheria), and mRNA vaccines (COVID-19 — Pfizer-BioNTech, Moderna) — all exploit immunological memory to provide protection without natural infection
Antimicrobial Agents — Mechanisms, Classes, and Selective Toxicity
An antimicrobial agent is a substance that kills or inhibits the growth of microorganisms. The central principle governing antimicrobial pharmacology is selective toxicity — the agent must harm the microorganism more than the host. This selectivity is achieved by targeting structures or metabolic pathways that are unique to the pathogen (bacterial cell wall) or differ sufficiently between the pathogen and the human cell (bacterial ribosomes versus eukaryotic ribosomes) to allow pharmacological discrimination. Understanding the mechanism of action of each antibiotic class is the foundation for understanding spectrum of activity, resistance mechanisms, and drug combination rationale.
Relative coverage of major antibiotic classes across Gram-positive and Gram-negative bacteria
Cell Wall Synthesis Inhibitors
Beta-lactams (penicillins, cephalosporins, carbapenems, monobactams) bind penicillin-binding proteins (PBPs) — transpeptidases that cross-link peptidoglycan strands. Glycopeptides (vancomycin, teicoplanin) bind the D-Ala-D-Ala terminus of peptidoglycan precursors, preventing cross-linking. Both are bactericidal.
Protein Synthesis Inhibitors
30S-targeting: Aminoglycosides (irreversible binding, bactericidal), tetracyclines (reversible binding, bacteriostatic). 50S-targeting: Macrolides, lincosamides (clindamycin), chloramphenicol, linezolid, streptogramins — mostly bacteriostatic (linezolid is bacteriostatic; aminoglycosides bactericidal).
DNA/RNA Synthesis Inhibitors
Fluoroquinolones inhibit DNA gyrase (Gram-negative) and topoisomerase IV (Gram-positive). Rifampicin inhibits bacterial RNA polymerase β-subunit. Metronidazole — reduced to reactive intermediates that break DNA strands in anaerobic/microaerophilic bacteria and protozoa.
Antimicrobial Resistance — Mechanisms, Spread, and the Global Crisis
Antimicrobial resistance (AMR) is the ability of microorganisms to survive and grow in the presence of antimicrobial concentrations that would normally inhibit or kill them. It is one of the most critical global public health threats of the twenty-first century. The WHO global action plan on AMR warns that without concerted international action, AMR could kill 10 million people annually by 2050 — surpassing cancer as the leading cause of preventable death. The UK’s 2016 O’Neill Review estimated the current annual global death toll at approximately 700,000. Understanding AMR mechanisms is essential for students in microbiology, medicine, nursing, public health, and pharmacy.
Beta-Lactamase Production — Antibiotic Inactivation
Beta-lactamases are bacterial enzymes that hydrolyse the beta-lactam ring of penicillins and cephalosporins, rendering them inactive before they can reach their PBP target. Extended-spectrum beta-lactamases (ESBLs) — encoded on transferable plasmids — inactivate virtually all penicillins and cephalosporins except carbapenems. Carbapenemases — including KPC (Klebsiella pneumoniae carbapenemase), NDM-1 (New Delhi metallo-beta-lactamase), and OXA-48 — inactivate carbapenems (the last-resort antibiotics for ESBL organisms), producing carbapenem-resistant Enterobacterales (CRE) with very limited treatment options (colistin, ceftazidime-avibactam, imipenem-cilastatin-relebactam). Beta-lactamase inhibitors (clavulanate, tazobactam, sulbactam, avibactam) block these enzymes and restore beta-lactam activity.
Altered Target — Maintaining Function While Evading the Drug
Bacteria can modify the antibiotic target to reduce or eliminate drug binding while retaining the target’s biological function. MRSA (methicillin-resistant Staphylococcus aureus) carries the mecA gene (on the mobile genetic element SCCmec), encoding PBP2a — a modified PBP with very low affinity for virtually all beta-lactam antibiotics, making MRSA resistant to penicillins, cephalosporins, and carbapenems simultaneously. Vancomycin-resistant enterococci (VRE) carry the vanA gene cluster, encoding enzymes that modify the D-Ala-D-Ala peptidoglycan terminus to D-Ala-D-lactate — reducing vancomycin binding 1,000-fold. Fluoroquinolone resistance arises from point mutations in the quinolone resistance-determining regions (QRDR) of DNA gyrase and topoisomerase IV genes.
Efflux Pumps and Reduced Permeability
Efflux pumps actively export antibiotics from the bacterial cell before they reach inhibitory concentrations. The RND (resistance-nodulation-division) family efflux pumps in Gram-negative bacteria — particularly MexAB-OprM in P. aeruginosa and AcrAB-TolC in E. coli — export multiple structurally unrelated antibiotic classes simultaneously (multidrug efflux), contributing to intrinsic and acquired multidrug resistance. Overexpression of efflux pump genes (through promoter mutations or loss of repressors) is a common resistance mechanism for fluoroquinolones, tetracyclines, macrolides, and beta-lactams. Reduced outer membrane permeability — through loss or downregulation of porin proteins (OmpC, OmpF in E. coli; OprD in P. aeruginosa) — reduces antibiotic entry, particularly relevant for beta-lactams and carbapenems in Gram-negative organisms.
WHO Critical Priority Pathogens — The ESKAPE Organisms
The ESKAPE pathogens — Enterococcus faecium (VRE), Staphylococcus aureus (MRSA), Klebsiella pneumoniae (ESBL/CRE), Acinetobacter baumannii (carbapenem-resistant), Pseudomonas aeruginosa (multidrug-resistant), and Enterobacter species — represent the organisms most likely to cause healthcare-associated infections that are impossible or very difficult to treat with existing antibiotics. Acinetobacter baumannii poses particular challenges in ITU settings — carbapenem-resistant strains may be susceptible only to colistin (an old, nephrotoxic antibiotic), sulbactam combinations, or novel agents. WHO classifies these as critical priority for new antibiotic development.
Antimicrobial Stewardship — Managing Use to Preserve Efficacy
Antimicrobial stewardship programmes (ASPs) are coordinated, evidence-based interventions in healthcare settings designed to optimise antibiotic prescribing — using the right antibiotic, at the right dose, for the right duration, for the right indication. Core stewardship interventions include prospective audit and feedback, formulary restriction and prior authorisation for broad-spectrum agents, de-escalation from broad to narrow-spectrum therapy once culture results are available, and duration limitation. In the community, stewardship addresses over-prescribing for viral respiratory infections — a major driver of resistance that affects both individual patients (disrupted microbiome, C. difficile risk) and the population (selecting resistant strains).
Phage Therapy, Bacteriocins, and the New Antibiotic Pipeline
The antibiotic discovery pipeline — dormant for 30 years as pharmaceutical companies withdrew from antimicrobial R&D — is slowly reviving. New agents approved in the past decade include ceftolozane-tazobactam and ceftazidime-avibactam (anti-ESBL/CRE agents), imipenem-cilastatin-relebactam, and cefiderocol. Bacteriophage therapy — using bacterial viruses to target specific pathogens — is being revived for compassionate-use treatment of infections with absolutely no antibiotic options, particularly in prosthetic joint and endocarditis infections. Antimicrobial peptides, anti-biofilm strategies, quorum sensing inhibitors, and microbiome modulation approaches represent alternative targets currently in earlier research stages.
The Human Microbiome — Our Microbial Companions and Their Clinical Significance
The human microbiome is the collective community of microorganisms — bacteria, archaea, viruses (phageome), and fungi (mycobiome) — residing in and on the human body. Each body site has a distinct microbial community shaped by local environmental conditions: the gut is dominated by anaerobic bacteria (Firmicutes and Bacteroidetes); the skin by aerotolerant, lipid-utilising organisms (Cutibacterium, Staphylococcus epidermidis); the oral cavity by Streptococcus, Veillonella, and Fusobacterium species; the vaginal microbiome by Lactobacillus species that maintain a protective acidic pH. The relationship between the microbiome and human health is one of the most rapidly expanding areas in biomedical science.
Microbial cells in and on the human body — and their collective metabolic contribution to human physiology
The gut microbiome alone has a collective genome (the gut metagenome) approximately 100–150 times the size of the human genome. These microorganisms produce short-chain fatty acids (butyrate, propionate, acetate) from fermentation of dietary fibre — providing approximately 10% of dietary calories, maintaining gut barrier integrity, and suppressing inflammation. They synthesise vitamins K and several B vitamins; train the mucosal immune system by driving IgA class-switching and Treg development; and metabolise bile acids, xenobiotics, and drugs in ways that influence systemic pharmacology and toxicology.
The microbiome is not a passenger — it is a metabolic organ. Its collective enzymes, transporters, and signalling molecules interact with human physiology at every level, from immune training in infancy to drug metabolism in adults. We are not individuals; we are ecosystems.
Principle reflected in microbiome research literature including work from the Human Microbiome Project Consortium (Nature, 2012) and Rob Knight’s microbiome research programme
Clostridioides difficile infection is one of the clearest demonstrations of microbiome disruption causing disease: broad-spectrum antibiotics eliminate the protective commensal flora, allowing C. difficile spores to germinate and produce toxins that cause colitis. The treatment — faecal microbiota transplantation — is one of the most effective therapies in infectious disease, with 90%+ cure rates for recurrent infection.
Reflecting clinical evidence for FMT efficacy from multiple randomised controlled trials reviewed in clinical gastroenterology and infectious disease literature
Clostridioides (formerly Clostridium) difficile infection (CDI) exemplifies the clinical consequences of microbiome disruption with particular clarity. C. difficile spores, ubiquitous in the hospital environment, are ingested and typically eliminated by the intact commensal flora through competitive exclusion. Broad-spectrum antibiotic use disrupts this community, reducing colonisation resistance and allowing C. difficile to germinate, colonise the colon, and produce toxins A (enterotoxin) and B (cytotoxin) that cause colitis ranging from mild diarrhoea to life-threatening pseudomembranous colitis. Faecal microbiota transplantation (FMT) — the transfer of processed stool from a healthy donor to a CDI patient — restores a normal microbiome and achieves cure rates of approximately 90% in recurrent CDI, far exceeding the 50–60% cure rates of antibiotic retreatment alone. FMT represents one of the most dramatic demonstrations of microbiome-based therapeutics and has catalysed broader interest in microbiome manipulation for conditions including inflammatory bowel disease, metabolic syndrome, and even neurological disorders.
Microbiology Laboratory Techniques — From Culture to Molecular Diagnosis
Clinical and research microbiology relies on a portfolio of techniques for isolating, identifying, and characterising microorganisms, and for detecting them in clinical samples. The transition from conventional culture-based methods to molecular diagnostics has transformed the speed, sensitivity, and scope of microbiological investigation — but culture remains essential for antimicrobial susceptibility testing, outbreak investigation, and identification of novel organisms.
Culture and Sensitivity
Growth on selective and differential culture media, followed by antibiotic susceptibility testing (disc diffusion — Kirby-Bauer; broth microdilution for minimum inhibitory concentrations). Remains gold standard for identifying treatable pathogens and directing targeted therapy. MALDI-TOF mass spectrometry has replaced biochemical identification panels for rapid, accurate species identification from colonies.
Molecular Diagnostics
PCR (polymerase chain reaction) detects microbial DNA/RNA in clinical samples within hours — with sensitivity and specificity exceeding culture for many pathogens. Multiplex PCR panels simultaneously test for multiple pathogens (e.g. FilmArray respiratory panel: 20+ respiratory viruses and bacteria). Whole-genome sequencing (WGS) for outbreak investigation and resistance gene identification. Metagenomics for culture-negative infections.
Serology and Rapid Antigen Tests
ELISA, immunofluorescence, and agglutination tests detect host antibodies (IgM/IgG) or microbial antigens in serum, urine, or swabs. Rapid antigen tests (lateral flow immunoassays) — including COVID-19 rapid antigen tests, influenza tests, and Streptococcus group A throat swab tests — provide point-of-care results in 15–30 minutes, enabling immediate clinical decision-making. Sensitivity varies significantly by pathogen and clinical context.
For students studying microbiology at all levels — from first-year undergraduate surveys of microbial diversity through postgraduate infectious disease programmes — the range of content is vast and the connections to clinical, pharmaceutical, and public health practice are direct and immediate. Primary literature in microbiology includes journals such as mBio — the American Society for Microbiology’s open-access flagship journal — which publishes cutting-edge research across the full breadth of microbiology and is freely accessible for student reading. Our biology assignment help, nursing assignment help, public health assignment help, and science writing services support microbiology-related assignments across all formats and academic levels — from laboratory reports and case studies through to systematic literature reviews and postgraduate dissertations.
Microbiology Academic Support — All Levels and Assignment Types
From undergraduate bacteriology essays and nursing microbiology case studies to postgraduate research papers on antimicrobial resistance — specialist writers with subject expertise in clinical and molecular microbiology provide accurate, targeted academic support.
Frequently Asked Questions About Microbiology
Explore further: biology assignment help · nursing assignment help · public health assignment help · science writing services · research paper writing · biology research paper · literature review writing · dissertation support · nursing case studies · biostatistics help · lab report writing · complex scientific assignments · challenging research topics · nursing research papers